China ‘s State Food and Drug Administration (SFDA) has recently been making greater efforts to improve its pharmaceutical industry, including the protection and quality of drugs on the market in China. On March 2, 2005, the National Drug Registration Working Conference was... Read More
While both the U.S. and European over-the-counter (OTC) drug markets are mature, valued at approximately $30 billion and $24 billion respectively, it is Asia’s OTC market that is showing the fastest growth. Many countries in Asia are experiencing strong economic growth, and... Read More
The Ministry of Health (MOH) announced that they are considering submitting a recommendation to the State Council to ban the advertising of medical services in China. There is also support for extending the proposed ban to include drug advertisements as well. The... Read More
Currently, China’s medical device market is worth approximately $3.5 billion. Moreover, the number of foreign companies registering medical devices in China nearly doubled between 2003 and 2004. The State Food and Drug Administration (SFDA), which regulates medical devices in China, has been... Read More
To expand their sales in the Asian medical markets, medical companies need to stay abreast of the new and changing regulatory environments for drugs, devices and In Vitro Diagnostics (IVDs). New or improved regulations are implemented frequently in Asia, including changes in... Read More
In 1998, China’s State Food and Drug Administration (SFDA) introduced Good Manufacturing Practice (GMP) certification in order to emphasize quality and safety of pharmaceutical production. However, the certification was optional and occurrences of medical accidents and legal issues continued to arise due... Read More
One of the fastest growing economies in the world today is China, growing at a rate of around 9 percent per year. The country's medical device market is currently worth approximately $3.5 billion. Following China's entry into the World Trade Organization (WTO),... Read More
The Chinese medical device market is currently worth about $2.5 billion and it is growing rapidly. Exporting to China is becoming easier and tariffs on most medical devices have been reduced to 3.9% as of January 1, 2005. The U.S. is the... Read More
Since the middle of December, China’s medicine retailing market has been fully open to foreign companies. Predictions that foreign medicine retailers would take this opportunity to pour investment into the country have proven to be overly optimistic. Low profit margins and a... Read More
To strengthen the supervision of pharmaceutical companies in China, the State Food and Drug Administration (SFDA) issued the Interim Provisions for Drug Safety Credit Classification on September 13, 2004. The new regulation will categorize domestic and foreign drug companies, including manufactures, distributors,... Read More